Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A double-blind randomized controlled trial was carried out to assess the effect of sour milk, containing two tripeptides (valine-proline-proline and isoleucine-proline-proline), on blood pressure (BP). METHODS: A total of 46 borderline hypertensive men aged 23 to 59 years were recruited at their workplace for this trial. Subjects were randomly allocated into two groups; sour milk drink group (S-group, n = 23) and placebo (acidified milk) drink group (P-group, n = 23) for 4 weeks. Blood pressure was measured twice at each occasion by a physician, at the health center of the company, with a mercury at baseline, 2 and 4 weeks. Statistical analysis was performed by SPSS 10.0J. RESULTS: The S-group and P-group showed no significant difference in baseline systolic BP (mean [SD], S: 147.6 [9.6], P: 145.3 [13.0]) or diastolic BP (S: 95.3 [9.9], P: 91.5 [9.6]). In the S-group, change in systolic BP at 2 and 4 weeks were -4.3 mm Hg (95% confidence interval [CI] -8.3 to -0.4; P = .032) and -5.2 mm Hg (95% CI -10.1 to -0.3; P = .039), both statistically significant. Diastolic BP showed change from -1.7 mm Hg (95% CI -5.4 to 2.0) at 2 weeks and -2.0 (95% CI -5.4 to 1.5) at 4 weeks, respectively. In the P-group, change in systolic BP were -0.5 (95% CI -5.8 to 4.8) at 2 weeks and -3.7 (95% CI -8.3 to 0.9) and change in diastolic BP were -0.6 (95% CI -4.7 to 3.6) and -0.3 (95% CI -3.9 to 3.3), which were not statistically significant. CONCLUSIONS: This trial demonstrated the beneficial effect of sour milk on BP in borderline hypertensive men who were not taking antihypertensive medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Yamamoto, N., Akino, A., & Takano, T. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)77026-0 · Cited by 418
Cited by
Bioactive peptides: Production and functionality
Korhonen, H., & Pihlanto, A. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.10.012 · Cited by 1,737
Food-derived peptides with biological activity: from research to food applications.
Hartmann, R., & Meisel, H. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.013 · Cited by 1,102
“FFVAP, FALPQY, VPP) [43] Egg Ovotransferrin KVREGTTY [44] Ovalbumin Ovokinin (FRADHPPL) [45] Ovokinin (2–7) (KVREGTTY) Wheat Wheat gliadin IAP [46] Broccoli Plant protein YPK [47] Immunomodulatory Rice Rice albumin Oryzatensin (GYPMYPLR) [48] Egg Ovalbumin Peptides not specified [49 ] Milk a-, b-, k-CN, a-LA Immunopep…”
BackgroundMilk-derived bioactive peptides: From science to applications
Korhonen, H. (2009) · Journal of Functional Foods · doi:10.1016/j.jff.2009.01.007 · Cited by 700
Antihypertensive peptides: Production, bioavailability and incorporation into foods
Hernández-Ledesma, B., del Mar Contreras, M., & Recio, I. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.11.001 · Cited by 511
(2007) · doi:10.1007/978-3-540-37885-3 · Cited by 476
López-Fandiño, R., Otte, J., & van Camp, J. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.004 · Cited by 382
Thirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
Bioactive peptides and lactic fermentations.
FITZGERALD, R. J., & MURRAY, B. A. (2006) · International Journal of Dairy Technology · doi:10.1111/j.1471-0307.2006.00250.x · Cited by 355
Phelan, M., Aherne, A., FitzGerald, R. J., & O'Brien, N. M. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.06.001 · Cited by 351
Bioactive peptides of animal origin: a review
Bhat, Z. F., Kumar, S., & Bhat, H. F. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1731-5 · Cited by 308
“…rat model and human studies have demonstrated antihypertensive capacity of these peptides (Hata et al. 1996; Masuda et al. 1996; Nakamura et al. 1995a, b; Sipola et al. 2002; Seppo et al. 2003; Mizushima et al. 2004; Aihara et al. 2005; Jauhiainen et al. 2005; Hirota et al. 2007; Korhonen 2009).”
Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases
Oniszczuk, A., Oniszczuk, T., Gancarz, M., & Szymańska, J. (2021) · Molecules · doi:10.3390/molecules26041172 · Cited by 276
Foltz, M., Meynen, E. E., Bianco, V., van Platerink, C., Koning, T. M. M. G., & Kloek, J. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.4.953 · Cited by 270
Cheese in nutrition and health
Walther, B., Schmid, A., Sieber, R., & Wehrmüller, K. (2008) · Dairy Science and Technology · doi:10.1051/dst:2008012 · Cited by 194
“helveticus [51, 63, 67, 93], as well as in humans [29, 57, 62, 84, 104].”
BackgroundDong, J.-Y., Szeto, I. M. Y., Makinen, K., Gao, Q., Wang, J., Qin, L.-Q., & Zhao, Y. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001712 · Cited by 145
Effect of Probiotics on Blood Lipid Concentrations: A Meta-Analysis of Randomized Controlled Trials
Cho, Y. A., & Kim, J. (2015) · Medicine · doi:10.1097/md.0000000000001714 · Cited by 143
“bias: neither the participants nor the evaluators were blinded in 4 studies,(13,17,18,30) and the details of dropout were not reported in 3 studies.(14,28,36) Most studies did not describe the randomization sequence generation, allocation concealment, or blinding of outcome assessment; thus, they were rated as having…”
BackgroundRicci-Cabello, I., Olalla Herrera, M., & Artacho, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00448.x · Cited by 142
Metadata
- Authors
- MIZUSHIMA, S.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 17
- Issue
- 8
- Pages
- 701-706
- ISSN
- 0895-7061 (ISSN-L)
- OpenAlex
- W1978786474
- Cited by
- 154
- References
- 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.